| Name | Title | Contact Details |
|---|
Racemi is a pioneer in the server migration space. With “industry first” support for migrating application workloads between dissimilar physical, virtual, and cloud infrastructure, Racemi makes it possible for businesses to deploy applications to meet their business needs without fear of vendor lock-in. A Gartner Cool Vendor award winner and AWS APN Leadership Award Winner 2 years running, Racemi has hundreds of customers, users, and partners leveraging our technology in data centers around the world. The Racemi management team has over 50 years of combined experience with image-based server provisioning technology, products, and solutions.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
CyberForce|Q is a cybersecurity company that provides SOC as a Service, strategic guidance, and operational capability to drive quantifiable cybersecurity program advancement.
SiteTech Systems is a Murrells Inlet, SC-based company in the Software and Internet sector.
We are a rag-tag crew of engineers, designers, visionaries, and artists. Together, we formed InterFocus INC with the intention of utilizing the latest social network and big data technologies to forever improve the online shopping experience.